Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6503)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 15, 2021 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tuta M, Boc N, Brecelj E, Peternel M, Velenik V. Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure. World J Gastrointest Oncol 2021; 13(2): 119-130 [PMID: 33643528 DOI: 10.4251/wjgo.v13.i2.119] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v13/i2/119.htm |
| Number | Citing Articles |
| 1 |
Rongbo Wen, Leqi Zhou, Siyuan Jiang, Hao Fan, Kuo Zheng, Yue Yu, Xianhua Gao, Liqiang Hao, Zheng Lou, Guanyu Yu, Fu Yang, Wei Zhang. DSTN Hypomethylation Promotes Radiotherapy Resistance of Rectal Cancer by Activating the Wnt/β-Catenin Signaling Pathway. International Journal of Radiation Oncology*Biology*Physics 2023; 117(1): 198 doi: 10.1016/j.ijrobp.2023.03.067
|
| 2 |
Zhou Ma, Ling Tan, Zi-lin Liu, Ling-han Tang, Jiangwei Xiao. Total Neoadjuvant Therapy or Standard Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3941038
|
| 3 |
Zhou Ma, Ling Tan, Zi-lin Liu, Jiang-wei Xiao. Total neoadjuvant therapy or standard chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.911538
|
| 4 |
M Chen, H Lin, J Zhang, X Pang, X Fan, S Luo, Z Liu, H Hu, S Lai, Y Hou, L Kang, L Huang. Presence and clinical significance of acellular mucin pools in resected rectal cancer with pathological complete response after pre‐operative chemoradiotherapy. Histopathology 2022; 81(5): 569 doi: 10.1111/his.14795
|
| 5 |
K S Poojashree, Tasneem Rushdi, A Krishnan Raju, Devender Reddy Boja. Clinical and dosimetric comparison of acute bowel toxicities in carcinoma rectum patients receiving neoadjuvant chemoradiotherapy by using standard 3DCRT VS IMRT. International journal of health sciences 2022; : 5171 doi: 10.53730/ijhs.v6nS1.6026
|
| 6 |
Mark Donnelly, Odhrán K Ryan, Éanna J Ryan, Ben Creavin, Mary O’Reilly, Ray McDermott, Rory Kennelly, Ann Hanly, Seán T Martin, Des C Winter. Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials. British Journal of Surgery 2023; 110(10): 1316 doi: 10.1093/bjs/znad177
|
| 7 |
Carolina Vigna, Ana Sofia Ore, Anne Fabrizio, Evangelos Messaris. Evaluation of racial/ethnic disparities in surgical outcomes after rectal cancer resection: An ACS-NSQIP analysis. Surgery in Practice and Science 2024; 17: 100248 doi: 10.1016/j.sipas.2024.100248
|
| 8 |
Qingbin Wu, Jiahao Zhou, Jun Huang, Xiangbing Deng, Changtao Li, Wenjian Meng, Yazhou He, Ziqiang Wang. Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis. British Journal of Surgery 2023; 110(7): 784 doi: 10.1093/bjs/znad120
|
| 9 |
Austin Fan, Beiqun Zhao, Peter Vu, Benjamin Abbadessa, Nicole Lopez, Samuel Eisenstein, Sonia Ramamoorthy, Shanglei Liu. Increased Pathologic Downstaging with Induction versus Consolidation Chemotherapy in Patients with Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy—A National Cancer Database Analysis. Journal of Clinical Medicine 2024; 13(3): 781 doi: 10.3390/jcm13030781
|